CENTENARY INSTITUTE OF CANCER MEDICINE AND CELL BIOLOGY

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 3252
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 297
 
  
 
C07K PEPTIDES 2134
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 2165
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 2204

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9879255 Modulation of RNA activity and vascular permeabilityOct 02, 13Jan 30, 18[A61K, C07H, C12N]
9610337 Prevention and treatment of mycobacterium infectionDec 20, 12Apr 04, 17[A61K, C12N, C07K]
9320755 Therapeutic and diagnostic moleculesJun 04, 10Apr 26, 16[C07H, A61K, C12N]
9291623 Kit for identifying regulatory T cellsApr 15, 11Mar 22, 16[C12N, G01N, C07K]
7947464 Method for identifying regulatory T cellsJul 31, 06May 24, 11[G01N]

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2012/0053,222 Novel Metabolic Disease TherapyAbandonedJan 22, 10Mar 01, 12[A61K, A61P]
2008/0227,096 Assay for response to proteasome inhibitorsAbandonedDec 07, 07Sep 18, 08[C12Q]
7083798 Method of immunomodulatory treatment of insulin dependent diabetes mellitus using mycobacterial cell wall compositionsExpiredNov 13, 97Aug 01, 06[A61K]
2004/0156,832 Immunoglobulin compositions and methodsAbandonedSep 26, 03Aug 12, 04[A61K, C12N]
2004/0146,948 Compositions and methods for targeting antigen-presenting cells with antibody single-chain variable region fragmentsAbandonedOct 17, 03Jul 29, 04[G01N, C07K]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.